Avery W. Catlin

Chief Financial Officer, Celldex Therapeutics.

Companies

Corbus PharmaceuticalsBoard member Nov 25, 2014 to Jun 3, 2024¹
Provention Bio, Inc.Board member Sep 5, 2018 to Apr 27, 2023²
Celldex TherapeuticsChief financial officer Jan 10, 2006 to Sep 7, 2016³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Corbus Pharmaceuticals CRBP4,350 shares⁴$19.7K at $4.52May 30, 2024
Provention Bio, Inc.10,000 shares⁵Apr 27, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

May 30, 2024Granted 2,783 shares of Corbus Pharmaceuticals⁴
Apr 27, 2023U 10,000 shares of Provention Bio, Inc.⁵
Apr 27, 2023U 10,000 shares of Provention Bio, Inc.⁵
Apr 13, 2023Gift 10,000 shares of Provention Bio, Inc.⁶
Apr 13, 2023Gift 10,000 shares of Provention Bio, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCorbus Pharmaceuticals, Board member
2
SEC EDGARProvention Bio, Inc., Board member
3
SEC EDGARCelldex Therapeutics, Chief financial officer
4
SEC EDGARCorbus Pharmaceuticals shares after the filing of May 30, 2024
5
SEC EDGARProvention Bio, Inc. shares after the filing of Apr 27, 2023
6
SEC EDGARForm 4 filed Apr 14, 2023